Cytomegalovirus UL97 mutations affecting cyclopropavir and ganciclovir susceptibility

Sunwen Chou, Terry L. Bowlin

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Among the 7 most common UL97 mutations encountered in ganciclovir-resistant clinical cytomegalovirus isolates, the associated cyclopropavir cross-resistance varies from insignificant (L595S) to substantial (M460I and H520Q) as determined by recombinant phenotyping. Mutations M460I and H520Q were preferentially selected in vitro under cyclopropavir and conferred 12- to 20-fold increases in 50% effective concentration (EC50) values, while M460V, C592G, A594V, and C603W conferred 3- to 5-fold increases. Uncommon mutations M460T and C603R increased cyclopropavir EC50s by 8- to 10-fold.

Original languageEnglish (US)
Pages (from-to)382-384
Number of pages3
JournalAntimicrobial Agents and Chemotherapy
Volume55
Issue number1
DOIs
StatePublished - Jan 2011

Fingerprint

Ganciclovir
Cytomegalovirus
Mutation
cyclopropavir

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology
  • Infectious Diseases

Cite this

Cytomegalovirus UL97 mutations affecting cyclopropavir and ganciclovir susceptibility. / Chou, Sunwen; Bowlin, Terry L.

In: Antimicrobial Agents and Chemotherapy, Vol. 55, No. 1, 01.2011, p. 382-384.

Research output: Contribution to journalArticle

@article{0964ed6fe28847f68df90e9c4adab9e4,
title = "Cytomegalovirus UL97 mutations affecting cyclopropavir and ganciclovir susceptibility",
abstract = "Among the 7 most common UL97 mutations encountered in ganciclovir-resistant clinical cytomegalovirus isolates, the associated cyclopropavir cross-resistance varies from insignificant (L595S) to substantial (M460I and H520Q) as determined by recombinant phenotyping. Mutations M460I and H520Q were preferentially selected in vitro under cyclopropavir and conferred 12- to 20-fold increases in 50{\%} effective concentration (EC50) values, while M460V, C592G, A594V, and C603W conferred 3- to 5-fold increases. Uncommon mutations M460T and C603R increased cyclopropavir EC50s by 8- to 10-fold.",
author = "Sunwen Chou and Bowlin, {Terry L.}",
year = "2011",
month = "1",
doi = "10.1128/AAC.01259-10",
language = "English (US)",
volume = "55",
pages = "382--384",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "0066-4804",
publisher = "American Society for Microbiology",
number = "1",

}

TY - JOUR

T1 - Cytomegalovirus UL97 mutations affecting cyclopropavir and ganciclovir susceptibility

AU - Chou, Sunwen

AU - Bowlin, Terry L.

PY - 2011/1

Y1 - 2011/1

N2 - Among the 7 most common UL97 mutations encountered in ganciclovir-resistant clinical cytomegalovirus isolates, the associated cyclopropavir cross-resistance varies from insignificant (L595S) to substantial (M460I and H520Q) as determined by recombinant phenotyping. Mutations M460I and H520Q were preferentially selected in vitro under cyclopropavir and conferred 12- to 20-fold increases in 50% effective concentration (EC50) values, while M460V, C592G, A594V, and C603W conferred 3- to 5-fold increases. Uncommon mutations M460T and C603R increased cyclopropavir EC50s by 8- to 10-fold.

AB - Among the 7 most common UL97 mutations encountered in ganciclovir-resistant clinical cytomegalovirus isolates, the associated cyclopropavir cross-resistance varies from insignificant (L595S) to substantial (M460I and H520Q) as determined by recombinant phenotyping. Mutations M460I and H520Q were preferentially selected in vitro under cyclopropavir and conferred 12- to 20-fold increases in 50% effective concentration (EC50) values, while M460V, C592G, A594V, and C603W conferred 3- to 5-fold increases. Uncommon mutations M460T and C603R increased cyclopropavir EC50s by 8- to 10-fold.

UR - http://www.scopus.com/inward/record.url?scp=78650664958&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650664958&partnerID=8YFLogxK

U2 - 10.1128/AAC.01259-10

DO - 10.1128/AAC.01259-10

M3 - Article

C2 - 21041510

AN - SCOPUS:78650664958

VL - 55

SP - 382

EP - 384

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 1

ER -